GPT and metabolic syndrome: As shown in Table 1, there was a significant statistical difference observed between MetS patients with and without hepatic steatosis in terms of their education level, hepatitis, CVD, ALT, drug for diabetes, drug for hypertension, protein, HOMA-IR, TyG index, TyG-WHtR, and METS-IR (all P < 0.05).